Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soft Gel Technologies is a U.S.-based private contract manufacturer focused on premium soft gelatin capsule products for the dietary supplement and nutraceutical industry. The company provides full-service development and manufacturing, including custom formulation, bulk stock softgels, branded ingredients and formulas, encapsulation, bottling, and related commercialization support. It emphasizes patented and proprietary technologies designed to improve nutrient bioavailability and handle ingredients that are difficult to absorb, difficult to encapsulate, or formulation-sensitive. In addition to contract manufacturing, the company markets a portfolio of branded softgel products such as omega-3, hyaluronic acid, coenzyme Q10, phosphatidylserine, and botanical formulations. Operations are centered in the Los Angeles/Commerce, California area, and the business operates as a subsidiary of Japan-based Kenko Corporation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soft Gel Technologies.